BMO Capital Markets (:) has been given an average recommendation of “N/A” by the zero research firms that are covering the firm, MarketBeat reports.
TRADEMARK VIOLATION WARNING: This piece was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://www.com-unik.info/2017/08/19/0-24-eps-expected-for-sangamo-therapeutics-inc-sgmo-this-quarter-updated-updated.html.
BMO Capital Markets Company Profile
BMO Capital Markets is the investment banking and capital markets arm of Bank of Montreal, aka BMO Financial Group. It serves corporate, institutional, and government clients in North America, providing equity and debt underwriting, corporate lending and project finance, M&A advisory, and equity and debt research.
What are top analysts saying about BMO Capital Markets? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for BMO Capital Markets and related companies.